flow rate of 1 mL/min at 55°C. PNA, Peptides and conjugates were analyzed by Acquity ultraperformance liquid chromatography system from Waters (Eschborn, Deutscland) and a BEH130 C18 (2.1x50mm, 1.7µm) column with a binary mixture of the solvents A (98.9% H2O, 1% MeCN, 0.1% TFA) and B (98.9% MeCN, 1% H2O, 0.1% TFA) at 50°C and 0.5 mL/min flow rate in a linear gradient shown in table 2.
Oligonucleotides and oligonucleotide conjugates were purified by reversed-phase HPLC (DMT-on and -off) by using a 1105 Gilson HPLC and a YMC Triat C18 (150x10 mm, 5 µm) column at 8 mL/min flow rate or a YMC Triat C18 (250 x 4.6 mm, 5µm) at 1.5 mL/min flow rate and 55°C with a binary mixture of A (0.1 M TEAA buffer, pH = 7.5, aq.) and B (acetonitrile). Oligonucleotides and oligonucleotide conjugates were characterized on the YMC Triat C18 (250 x 4.6 mm, 5µm) column.
MALDI-TOF MS:
MALDI-TOF mass spectra were measured by using a Shimadzu Axima Confidence instrument in positive mode. The THPTA matrix was used (28 mg/mL 2',4',6'-trihydroxyacetophenonmonohydrate und 6 mg/mL citric acid diammonium salt in MeCN/H2O (1:1)).
Synthesis

Synthesis of PNA FIT probes and peptides
PNA and peptides were synthesized on a Tentagel ® R RAM resin from Novabiochem (Schwalbach, Germany) in a 10 µmol scale. For the maleimide-containing peptides, the resin was allowed to swell in DMF/piperidine (4:1 [v/v]) for 15 min and then washed five times with DMF. Afterwards 4 eq of Fmoc-(Mmt)-Lys-OH, 4 eq Oxyma, 3.9 eq HCTU, 6 eq. DIPEA in DMF (0.2 M) were coupled 2 x 45 min at room temperature. The subsequent assembly of the peptide chain was performed by using an automatized peptide synthesizer from Intavis (Köln, Deutschland) and coupling Fmoc-protected amino acids according to manufacturer´s instructions. The removal of the Mmt-group was performed by treatment with 1% TFA in DCM, which was followed by a manual coupling of 6-maleinimidohexaonicacid. To release peptides the resin was treated with TFA/TIS/thioanisole (90/4/6) for 1.5h. The TFA extract was concentrated using an argon stream. For precipitation, the remaining solution was added to ice-cold ether. The precipitate was purified by preparative HPLC. For the synthesis of the DTNP-peptides, cysteine was coupled as N-terminal amino acid. The peptides were cleaved from the resin upon treatment of TFA/TIS/H2O/EDT (95.5/2/2/0.5) for 1.5h followed by a precipitation in ice-cold ether. The HPLC purified material (1 eq) was modified in a reaction with 2,2'-dithiobis(5-nitropyridine) (20 eq) in acetic acid/ water (3:1, 12 mM). After 12 h shaking the crude conjugate was purified by preparative HPLC. The synthesis of FIT-PNA was performed according to manufacturer's instructions. For installing the N-terminal thiol function, Fmoc-6-Ahx-OH and subsequently 3-tritylthio-propionic acid were manually coupled. For detachment, the PNA-resin was treated with TFA/TIS/H2O/EDT (95.5/2/2/0.5). The TFA extract was concentrated using an argon stream. The remaining solution was added to ice-cold ether. The precipitate was purified by preparative HPLC.
Synthesis of DNA FIT probes
Automated DNA synthesis was performed by using a Bioautomation MerMade 4 synthesizer (Irving, Texas). All phosphoramidites were used according to manufacturer´s instructions. The yield of every coupling step was monitored by measuring the absorbance of the DMTr cleavage solution. The synthesis was programmed to yield the oligonucleotide carrying the DMTr protection group ("trityl-on").
Dyes and dye nucleotides were synthesized as described in former publications. [1] After completion of chain assembly the CPG was dried under vacuum. To remove the protecting groups and release the oligonucleotide the solid support was treated with 80% aqueous ammonia for 2.5 h at 55°C. The volatiles where removed under reduced pressure, the solid dissolved in water and the resulting solution filtered prior to HPLC purification. Afterwards, the DMTr group was removed upon treatment with 300 µL of 80% aqueous AcOH for 15 min at room temperature. The detritylation mixture was treated with 1 mL iPrOH and the resulting precipitate again purified by HPLC.
Synthesis of DNA/PNA-Peptide Conjugates via conjugate addition to maleimide
The Thiol-PNA was used for maleimide-ligation directly after HPLC purification. To reduce the disulfide protecting group DNA-based probes the oligonucleotide was dissolved (200µM) in a degassed TCEP buffer (5 mM TCEP, 10 mM NaCl, 10 mM NaHPO4, pH 6.5) and shaken at room temperature overnight. Afterwards the oligonucleotide was precipitated with 10% vol. 3 M ammonium acetate and 1 mL isopropanol. To prevent the oxidation of the thiol the probe was dried under argon. The thiololigonucleotide was dissolved (800 µM) in ligation buffer (10 mM NaCl, 10 mM NaH2PO4, pH 6.5) with 4 eq of maleimide peptides. The mixture was stirred for 2h. Urea buffer (0.1 M KH2PO4, 0.3 M KBr, 8 M Urea, 1 mM TCEP, pH 8) was added. The mixture was the stirred for 30 min. After filtration over a NAP column the conjugates were purified by HPLC.
Synthesis of PNA-disulfide-CPP-conjugates
To 1 eq. of thiol-PNA (100 µM) in buffer (1 M HEPES, 6 M Gn-HCl, pH 6.8) were added 4 eq of DTNPpeptide. The mixture was stirred for 1h at 25°C. Subsequently, the mixture was filtrated trough a NAP column prior to HPLC purification. Conditions: 0.5 µM probe und 5 eq. RNA target in PBS buffer (100 mM NaCl, 10 mM Na2HPO4, pH 7) at 37°C, TO= λex= 485 nm, λem= 535 nm, BO = λex= 440 nm, λem= 485 nm, QB = λex= 560 nm, λem= 605 nm slitex= 5 nm, slitem= 5 nm. 
Melting analysis of the FIT probes and FIT probe conjugates
For melting analysis, the absorbance at 260 nm was monitored during a thermal cycle (3 times 20-90 °C in 0.5 °C/min) with 1 eq of RNA target. The probes were dissolved at 1 µM or 0.5 µM concentration using PBS (100 mM NaCl, 10 mM Na2HPO4, pH 7).
Melting curves at 1 µM concentration Figure S4 . Normalized melting curve (black) and derivation (grey). Conditions: 1 µM probe and 1 eq. RNA target in PBS (100 mM NaCl, 10 mM Na2HPO4, pH 7) 20-90 °C. λem= 260 nm. Figure S6 . Melting curve (black) and derivation (grey). Conditions: 0.5 µM probe und 1 eq. RNA target in PBS buffer (100 mM NaCl, 10 mM Na2HPO4, pH 7) 20-90 °C. λem= 260 nm.
Permanent transfection of Flp-In TM 293 T-Rex cells TM with F-tagged mCherry
To express a repeat sequence of mRNA together with an mCherry open reading frame under control of an inducible promoter, we employed oligo condensation and MultiSite-Gateway TM recombination cloning from Invitrogen (Carlsbad, USA). First, we designed a synthetic 22 nt long RNA sequence.
Unique sequence identity was verified by BLAST search in the human genome. We then synthesized complementary oligonucleotides (5' GATCCTAATCAACGGCCGGACGTGCATCTAATCAACGGCCGGACGTGCATA 3') containing two repeats of this binding sequence, phosphorylated them with polynucleotide kinase and hybridized them to form double stranded oligonucleotides with overhangs compatible with BamHI and BglII restriction sites. We polymerized these oligonucleotides in the presence of both restriction enzymes using T4 ligase, purified products of 300-500 bp length by agarose gel electrophoresis and cloned them into a custom gateway donor vector containing a stop codon in front of a multiple cloning site.
This resulted in a product with 9 repeats of the binding sequence in head-to-tail orientation, which was validated by sequencing. We repeatedly re-inserted this fragment using a terminal BamHI restriction site as well a BglII/XmaI sites to finally obtain a vector with 45 repeats of the binding sequence. To generate an expression plasmid we used previously generated donor vectors containing the mCherry ORF, as well as a CMV promoter followed by Tet-operators (CMV-TO). We then generated a fusion construct by three-fragment recombination (LR Clonase Plus) from Invitrogen (Carlsbad, USA) using all three donor plasmids and a custom destination vector containing R4 and R3 recombination sites for (Table S3) is shown with SD. Figure S13 . 1%-agarose gel analysis of SYBRGold™-stained mixtures of FIT-DNA1 and octaarginine at various positive/negative charge ratios P/N. Figure S14 . Magnified merged bright field and fluorescence microscopy images of permanently transfected FlpIn TM 293 T-REx TM cells without (-dox) and with (+dox) induction of F-tag-mCherry mRNA expression after incubation with DNA (2 µM) or PNA FIT probes (1 µM) for 30 min in PBS at 37 °C and 5% CO2. -dox, +dox = without and with addition of doxycycline (2 µg/ mL) 1 h before incubation with probes. Filter sets: TO ex = 500/24 nm, TO em = 545/40 nm.
Transfection over night
The cells were incubated over night with probe (1 µM FIT-DNA1 or 250 nM FIT-PNA2) in antibiotic free DMEM at 37°C and 5 % CO2. 2 µg/ mL doxycycline was added and after 1 h the cells were washed twice with DPBS + 1 mM MgCl2, and imaged in DPBS or for longer time in phenol red free DMEM. 
